(Q35557648)

8 August 2017

1 reference

title

Turning cell cycle controller genes into cancer drugs. A role for an antiproliferative cytokine (betaGBP). (English)

1 reference

8 August 2017

Derek Davies

4

1 reference

ORCID Public Data File 2021

author name string

Livio Mallucci

series ordinal

1

1 reference

8 August 2017

Valerie Wells

series ordinal

2

1 reference

8 August 2017

Antonios Danikas

series ordinal

3

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

8 August 2017

published in

Biochemical Pharmacology

1 reference

8 August 2017

volume

66

1 reference

8 August 2017

issue

8

1 reference

8 August 2017

page(s)

1563-1569

1 reference

Apoptosis: a link between cancer genetics and chemotherapy

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Integrating genetic approaches into the discovery of anticancer drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Mechanism-based target identification and drug discovery in cancer research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

The EGF receptor family as targets for cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Prospects for targeting the Bcl-2 family of proteins to develop novel cytotoxic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Farnesyltransferase inhibitors: promises and realities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Rational therapeutic intervention in cancer: kinases as drug targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Targeting RAS signalling pathways in cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Apoptosis-targeted therapies for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

STI571: targeting BCR-ABL as therapy for CML.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Mechanisms of resistance imatinib (STI571) in preclinical models and in leukemia patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Modelling the molecular circuitry of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Identification of an autocrine negative growth factor: mouse beta-galactoside-binding protein is a cytostatic factor and cell growth regulator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Molecular expression of the negative growth factor murine beta-galactoside binding protein (mGBP)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Structure and expression of the negative growth factor mouse beta-galactoside binding protein gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Mapping on Human and Mouse Chromosomes of the Gene for the β-Galactoside-Binding Protein, an Autocrine-Negative Growth Factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Translocation involving chromosome 22 in Ewing's sarcoma. A cytogenetic study of four fresh tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Recurrent breakpoints at 9q31 and 22q12.2 in extraskeletal myxoid chondrosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Chromosomal abnormalities in clear cell sarcoma. Implications for histogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Abnormalities of chromosome 22 in human brain tumors determined by combined cytogenetic and molecular genetic approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Negative cell cycle control of human T cells by beta-galactoside binding protein (beta GBP): induction of programmed cell death in leukaemic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Cell cycle arrest and induction of apoptosis by beta galactoside binding protein (beta GBP) in human mammary cancer cells. A potential new approach to cancer control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Dysregulation of apoptosis in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Apoptosis and cancer chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Proliferation, cell cycle and apoptosis in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

A matter of life and death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Apoptosis-based therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

7 January 2021

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Deconstruction of p53 functions and regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Checkpoints: controls that ensure the order of cell cycle events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Cell cycle control and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Cell cycle checkpoints: preventing an identity crisis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Regulation of cell proliferation by the E2F transcription factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Apoptosis induction by E2F-1 via adenoviral-mediated gene transfer results in growth suppression of head and neck squamous cell carcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Apaf-1 is a transcriptional target for E2F and p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Direct coupling of the cell cycle and cell death machinery by E2F.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Blocking the transcription factor E2F/DP by dominant-negative mutants in a normal breast epithelial cell line efficiently inhibits apoptosis and induces tumor growth in SCID mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

Labelling DNA strand breaks with BrdUTP. Detection of apoptosis and cell proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900512-4

10.1016/S0006-2952(03)00512-4

7 January 2021

Identifiers

DOI

1 reference

8 August 2017

1 reference